论文部分内容阅读
我们于76年11月开始用全国三尖杉协作组供应的三尖杉酯碱(批号761029)和高三尖杉酯碱(批号761120)分别治疗20例急性非淋巴性白血病。可供疗效分析的有18例,现初步报告如下: 病例选择及用药方法病例选择:我们以急粒、急单、红白血病作为研究对象,三尖杉酯碱组8例,急单5例,急性早幼粒3例。高三尖杉酯碱组10例,急粒3例,急性早幼粒4例,急单1例,红白血病2例。在18例中初治15例,复治3例。观察方法:根据病史、体检、血及尿常规、骨髓象、肝功能、肾功能及心电图等检
We started treatment of 20 cases of acute non-lymphatic leukemia with harringtonine (lot # 761029) and homoharringtonine (lot # 761120) from November of each year. Efficacy for the analysis of 18 cases, the initial report is as follows: Case Selection and Medication Methods Case Selection: We take the acute pellet, urgent orders, erythroleukemia as the research object, Harringtonine group of 8 cases, 5 cases of urgent orders, 3 cases of acute promyelocytic. Homoharringtonine group 10 cases, 3 cases of acute grain, acute promyelocytic 4 cases, 1 case of acute one, erythroleukemia in 2 cases. In 18 cases, 15 cases were initially treated and 3 cases were treated by retreatment. Observations: According to medical history, physical examination, blood and urine, bone marrow, liver function, renal function and ECG test